Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study
Year: 2006
Type: article
Study design: Observational Study
Source: Arthritis & Rheumatism
DOI: 10.1002/art.22331
Authors: Kimme L. Hyrich, Mark Lunt, Kath D. Watson, Deborah P. M. Symmons, Alan J. Silman, British Society for Rheumatology Biologics Register
Institution: University of Manchester
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2014709373
